Drug Shortage Report for TEVA-DEFERASIROX
| Report ID | 96730 |
| Drug Identification Number | 02407973 |
| Brand name | TEVA-DEFERASIROX |
| Common or Proper name | DEFERASIROX |
| Company Name | TEVA CANADA LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | DEFERASIROX |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET FOR SUSPENSION |
| Route of administration | ORAL |
| Packaging size | 30 |
| ATC code | V03AC |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2019-10-16 |
| Estimated end date | 2019-10-25 |
| Actual end date | 2019-10-25 |
| Shortage status | Resolved |
| Updated date | 2019-10-26 |
| Company comments | Product is discontinued. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2019-10-26 | English | Compare |
| v4 | 2019-10-25 | French | Compare |
| v3 | 2019-10-25 | English | Compare |
| v2 | 2019-10-17 | French | Compare |
| v1 | 2019-10-17 | English | Compare |
Showing 1 to 5 of 5